{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-24-001915","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2024-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.012000+00:00","generated_at":"2026-05-29T00:18:38.627946+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Artelo Biosciences announces annual meeting results; re-elects directors and ratifies auditor","bullets":["40.9% of shares represented at Dec 20, 2024 annual meeting (1,319,986 of 3,227,700 outstanding).","Directors Steven Kelly and R. Martin Emanuele re-elected to Class I board seats until 2027.","Ratification of Malone Bailey LLP as independent auditor for FY ending Dec 31, 2024 (1,258,378 for, 57,083 against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-24-001915","json":"https://secwatch.observer/filing/0001640334-24-001915.json","markdown":"https://secwatch.observer/filing/0001640334-24-001915.md","text":"https://secwatch.observer/filing/0001640334-24-001915.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424001915/0001640334-24-001915-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033424001915/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T00:18:38.627946+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}